Related references
Note: Only part of the references are listed.Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor
Veronica H. Flood et al.
BLOOD (2010)
Genetic testing for von Willebrand disease: the case for
I. R. Peake et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Genetic testing for von Willebrand disease: the case against
E. J. Favaloro
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping
Michael C. Campbell et al.
Annual Review of Genomics and Human Genetics (2008)
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study
Paula D. James et al.
BLOOD (2007)
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
Anne Goodeve et al.
BLOOD (2007)
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
Sandra L. Haberichter et al.
BLOOD (2006)
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J. E. Sadler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Regulated release of VWF and FVIII and the biologic implications
SL Haberichter et al.
PEDIATRIC BLOOD & CANCER (2006)
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
A Tosetto et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease
LA O'Brien et al.
BLOOD (2003)
Share Paper
